Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Editas enters CRISPR agreement with Massachusetts General Hospital
Americas
Editas Medicine, a US genome-editing company, announced yesterday that it has entered into an exclusive licensing agreement with Massachusetts General Hospital to access CRISPR technology.   4 August 2016
Natco Pharma’s Tamiflu generic approved
Americas
Natco Pharma, an India-based drugs company, announced today that it has received final approval from the US Food and Drug Administration to produce a generic version of Tamiflu.   4 August 2016
Pfizer expands gene therapy with Bamboo acquisition
Americas
Pfizer has acquired Bamboo Therapeutics, a biotechnology company based in North Carolina.   3 August 2016
Americas
Teva’s acquisition of Allergan’s generic business has been completed, the company revealed yesterday.   3 August 2016
Big Pharma
The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV.   2 August 2016
Europe
The English High Court has referred two questions on supplementary protection certificates to the Court of Justice of the European Union in a case between Merck Sharp & Dohme and the UK Intellectual Property Office.   2 August 2016
Americas
Law firm Akerman has hired Thomas Pasternak in the intellectual property practice group in Chicago.   2 August 2016
Big Pharma
The Alternative Dispute Resolution Forum has ruled in a case between Gilead Sciences and a company called PublicDomainRegistry.com, in another battle centred on Gilead’s hepatitis C drug Sovaldi.   1 August 2016
Americas
Novartis has filed complaint against Teva claiming the Israel-based company allegedly infringed one of its patents covering the drug Jadenu.   1 August 2016
Americas
Pharmaceutical company Vectura has sued GSK for allegedly infringing its patent after claiming that it refused to expand on a licensing agreement.   29 July 2016